Xvivo Perfusion Logo

Xvivo Perfusion

Develops ex-vivo machine perfusion systems to improve organ viability for transplantation.

XVIVO | ST

Overview

Corporate Details

ISIN(s):
SE0004840718 (+1 more)
LEI:
549300G2464FYLS14B41
Country:
Sweden
Address:
Gemenskapens Gata 9, 431 53 Mölndal
Sector:
Manufacturing
Industry:
Manufacture of medical and dental instruments and supplies

Description

Xvivo Perfusion is a medical technology company specializing in solutions for ex-vivo organ preservation. The company develops and markets innovative systems, solutions, and services that enable clinicians and researchers to preserve, assess, and transport donated organs—including lungs, hearts, livers, and kidneys—outside the body prior to transplantation. Its core offering is centered on machine perfusion technology, which aims to increase the availability and improve the quality of viable organs. Key products include the XPS™ (Ex Vivo Lung Perfusion System), Liver Assist™, and Kidney Assist Transport™, as well as the PERFADEX® Plus preservation solution. Xvivo's technologies are designed to extend organ preservation time, enhance assessment, and ultimately improve transplant outcomes, addressing the global shortage of transplantable organs.

Social Media

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-08-08 10:01
Major Shareholding Notification
Swedish 9.5 KB
2025-07-28 22:10
Legal Proceedings Report
Fördröjning i CE-godkännandeprocessen för XVIVOs perfusionslösning för hjärtpre…
Swedish 64.3 KB
2025-07-28 22:10
Legal Proceedings Report
Delay in CE approval for XVIVO’s perfusion solution for heart preservation
English 63.6 KB
2025-07-11 07:30
Interim Report
Swedish 2.0 MB
2025-07-11 07:30
Interim Report
English 2.0 MB
2025-04-25 14:25
Post-Annual General Meeting Information
Kommuniké från årsstämma i XVIVO Perfusion AB (publ)
Swedish 59.6 KB
2025-04-25 14:25
Post-Annual General Meeting Information
Bulletin from Annual General Meeting in XVIVO Perfusion AB (publ)
English 60.1 KB
2025-04-24 07:30
Quarterly Report
Swedish 1.9 MB
2025-04-24 07:30
Interim Report
English 6.8 MB
2025-03-20 17:45
Pre-Annual General Meeting Information
Notice to attend the annual general meeting in XVIVO Perfusion AB (publ)
English 111.0 KB
2025-03-20 17:45
Pre-Annual General Meeting Information
Kallelse till årsstämma i XVIVO Perfusion AB (publ)
Swedish 108.6 KB
2025-01-28 07:30
Earnings Release
Swedish 1.2 MB
2025-01-28 07:30
Annual / Quarterly Financial Statement
English 1.2 MB
2024-12-02 10:46
Major Shareholding Notification
Swedish 8.3 KB
2024-10-24 07:30
Quarterly Report
Swedish 1.2 MB

Automate Your Workflow. Get a real-time feed of all Xvivo Perfusion filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

No Financial Data Available

Standardized financial statements for the selected period are not yet available.

Need More History? Access decades of standardized financials for Xvivo Perfusion via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
2025-04-28 Lena Hagman Other Buy 1,500 466,500.00 SEK
2024-11-25 Christoffer Björn Rosenblad Other Sell 2,000 915,000.00 SEK
2024-02-29 Kristoffer Nordström Other Buy 335 88,440.00 SEK
2023-11-14 Gösta Johannesson Other Buy 500 124,500.00 SEK
2023-04-24 Lars Henriksson Other Buy 400 107,200.00 SEK
2022-11-02 Gösta Johannesson Other Buy 200 34,000.00 SEK
2022-11-01 Gösta Johannesson Other Buy 1,000 166,500.00 SEK
2022-08-19 Dag Andersson Tilk Other Buy 499 99,700.20 SEK
2022-05-24 Dag Andersson Tilk Other Other 5,417 1,115,251.96 SEK
2022-05-24 Christoffer Björn Rosenblad Other Other 2,708 557,523.04 SEK

Peer Companies

Company Country Ticker View
AuBEX CORPORATION Logo
High-precision manufacturer of nibs for stationery, cosmetics, and medical infusion technology.
Japan 3583
Audientes A/S Logo
Develops smart, self-fitting, and affordable hearing aids for adults with hearing loss.
Denmark AUDNTS
Bactiguard Holding Logo
Licenses a patented coating to MedTech partners to prevent medical device infections.
Sweden BACTI
BBS-Bioactive Bone Substitutes Oyj Logo
Developed a bioactive bone graft substitute for orthopedic surgery before filing for bankruptcy.
Finland BONE
BELLUSCURA PLC Logo
Develops portable oxygen concentrators for patients needing supplemental oxygen.
United Kingdom BELL
BENO TNR, Inc. Logo
A diversified firm in biotech, wearable robotics, and eco-friendly building materials.
South Korea 206400
BibbInstruments AB Logo
Develops electric endoscopic biopsy tools for accurate cancer diagnosis in GI, lung, and urology.
Sweden BIBB
BIOBIJOU Co., Ltd. Logo
Develops and manufactures injectable aesthetic solutions like HA fillers for global markets.
South Korea 489460
Biocartis Group NV Logo
Develops an automated PCR platform for fast molecular diagnostics in oncology & infectious diseases.
Belgium BCART
Biocorp Logo
Develops and manufactures connected drug delivery systems and medical devices for pharma.
France ALCOR

Talk to a Data Expert

Have a question? We'll get back to you promptly.